The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wickremasinghe, M. I.
Right arrow Articles by Friedland, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wickremasinghe, M. I.
Right arrow Articles by Friedland, J. S.
The Journal of Immunology, 1999, 163: 3936-3947.
Copyright © 1999 by The American Association of Immunologists

Pulmonary Epithelial Cells are a Source of IL-8 in the Response to Mycobacterium tuberculosis: Essential Role of IL-1 from Infected Monocytes in a NF-{kappa}B-Dependent Network1

Melissa I. Wickremasinghe, Lynette H. Thomas and Jon S. Friedland2

Department of Infectious Diseases, Imperial College of Science Technology and Medicine, Hammersmith Campus, London, United Kingdom


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Pulmonary epithelial cells, covering a 70-m2 surface area, have not previously been considered an important source of chemokines in pulmonary tuberculosis. We analyzed IL-8 secretion from A549 cells and primary normal human bronchial epithelial cells (NHBE) infected by Mycobacterium tuberculosis. Direct infection of A549 cells by M. tuberculosis caused IL-8 secretion of 7720 ± 1610 pg/106 cells, but no IL-8 secretion from NHBE after 24 h. In contrast, conditioned media from M. tuberculosis-infected human monocytes (CoMTB) induced a much greater IL-8 secretion of 92,635 ± 13,180 pg/106 A549 cells and 13,416 ± 3,529 pg/106 NHBE after 24 h. CoMTB induced rapid IL-8 mRNA accumulation, which was stable over 24 h, compared with TNF-{alpha}-induced transcripts. CoMTB stimulated nuclear binding of p65, p50, and c-Rel subunits of NF-{kappa}B to IL-8 promoter sequences. Transient transfections with IL-8 promoter reporter constructs showed NF-{kappa}B binding-site mutations abolished IL-8 promoter activity while NF-IL-6 binding-site mutations decreased promoter activity to 50.2 ± 6.3% of wild-type activity. IL-1R antagonist but not neutralizing anti-TNF-{alpha} inhibited epithelial cell IL-8 secretion, mRNA accumulation, and NF-{kappa}B binding. Recombinant IL-1ß (2 ng/ml) induced similar levels of IL-8 secretion to CoMTB in both A549 cells and NHBE. Pulmonary epithelial cells are a major source of IL-8 in the initial host response to pulmonary tuberculosis. Such IL-8 secretion is NF-{kappa}B dependent, NF-IL-6 requiring, and activated by an IL-1-mediated pathway as a consequence of phagocytosis of M. tuberculosis by monocytes.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mycobacterium tuberculosis is a principally pulmonary pathogen causing ~3 million deaths annually worldwide (1). The histological hallmark of the immune response to pulmonary tuberculosis is the formation of lung granulomas consisting of monocyte-derived cells and Ag-specific T lymphocytes. A prerequisite for granuloma formation is the recruitment of such cells to areas of infection. Chemokines have a pivotal role in controlling cellular influx into sites of infection (2). IL-8, first isolated from monocytes as a neutrophil attractant (3, 4, 5), is a CXC chemokine that is also chemotactic for T lymphocytes (6) and possibly monocytes (7). IL-8 recruits T lymphocytes stimulated with the purified protein derivative of M. tuberculosis (8) and critically was absolutely required for granuloma formation during in vivo mycobacterial challenge in rabbits (9). IL-8 has been found during human infection with M. tuberculosis in bronchoalveolar lavage fluid (BALF)3 (10, 11, 12), tuberculous lymph nodes (13), and in plasma, where IL-8 concentrations were higher in patients who died from tuberculosis than in survivors (14).

The pulmonary epithelium, covering a vast surface area of ~70 m2 (15), is a first line of defense to inhaled pathogens. The type II alveolar epithelial cell is known to contribute indirectly to immune responses during tuberculosis by its product surfactant protein A, which enhances macrophage phagocytosis of M. tuberculosis (16). Epithelial cells may also contribute directly to immune responses by secreting chemokines. Epithelial cells have been shown to secrete IL-8 and other chemokines following infection by pathogenic respiratory viruses (17, 18), bacteria (19, 20), and after stimulation with proinflammatory cytokines (21, 22, 23, 24). The cellular sources of the high IL-8 concentrations found in BALF of patients with pulmonary tuberculosis, and the mechanisms regulating this IL-8 release, have not been dissected. Alveolar macrophages phagocytosing M. tuberculosis are one source of IL-8 (11, 12, 25), but there are only few macrophages per alveolus. Virulent M. tuberculosis, strain H37-Rv, invades and replicates within alveolar epithelial cells at a low multiplicity of infection (MOI) of 1–10 (1–10 organisms per epithelial cell) (26, 27) and at a higher MOI of 10–20 after culture periods of over 4 days may be cytotoxic for epithelium (28). In addition, M. tuberculosis has recently been shown to directly stimulate pulmonary epithelial A549 cells to secrete a low level of IL-8 over 1–6 days (29), suggesting pulmonary epithelial cells are a source of IL-8 detected in BALF during disease.

The consequences of high-level IL-8 secretion during pulmonary tuberculosis will include neutrophil and T cell influx (30). BALF from patients with tuberculosis show dramatic increases in neutrophils, which are proportional to BALF IL-8 protein content (12). In addition, the extent of expression of IL-8 mRNA in tuberculous lymph node granulomas correlates with neutrophil infiltration (13). Neutrophils chemoattracted into the alveolus by IL-8 during pulmonary tuberculosis may be involved in host defense by themselves secreting chemokines (31), by releasing mediators such cathepsin G and azurocidin, which stimulate secondary T cell influx (32), and may also have a direct role in mycobacterial killing (33). Furthermore, IL-8, with its angiogenic properties (34), may be involved in tissue repair. However, an excess of neutrophils may contribute to the extensive lung damage often seen in pulmonary tuberculosis by generation of damaging free radicals (35), proteases, elastases (36), and matrix metalloproteinases (37, 38).

IL-8 secretion has been shown to be dependent on transcriptional activation of the IL-8 gene in a number of cell types (39, 40, 41). The IL-8 promoter region contains binding sites for a number of important transcription factors (42) including NF-{kappa}B, which comprises a family of Rel-related proteins that are normally retained in the cytoplasm bound to the inhibitor I{kappa}B{alpha} (43). Following cellular activation, I{kappa}B{alpha} is phosphorylated (44) on specific serine residues, ubiquinated, and degraded (45), allowing NF-{kappa}B to pass into the nucleus where it can bind to the IL-8 {kappa}B-binding site. This binding site is at position -80 to -71 in the IL-8 genome and adjacent to the NF-IL-6 binding site (42). Cooperative binding between NF-{kappa}B and NF-IL-6 has been demonstrated in alveolar epithelial cells infected with respiratory syncitial virus (46) and in TNF-{alpha}-stimulated HeLa cells (40), but did not occur in TNF-{alpha}-stimulated alveolar epithelial cells (47), suggesting that IL-8 gene activation is regulated in a cell type- and stimulus-specific manner.

The first aim of the present study was to determine whether pulmonary epithelial cells are involved in the secretion of IL-8 as a consequence of cytokine networks activated by monocyte phagocytosis of M. tuberculosis. The second aim was to analyze the role of NF-{kappa}B and NF-IL-6 in the control of IL-8 secretion by pulmonary epithelial cells. We demonstrate for the first time that pulmonary epithelial cells are a major source of IL-8 during the immune response to M. tuberculosis infection. Pulmonary epithelial cell IL-8 secretion is NF-{kappa}B dependent, NF-IL-6 requiring, and dependent on IL-1 secreted by M. tuberculosis-infected monocytes. In view of the large number of epithelial cells in the lung, such mechanisms will result in greater IL-8-dependent cell recruitment than either from phagocytosis of M. tuberculosis by monocytes or from direct infection of epithelial cells.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials

DMEM and RPMI 1640 media were obtained from Life Technologies (Paisley, U.K) and Dubos’ media from Difco (Detroit, MI). Normal human primary bronchial epithelial cells and bronchial epithelial growth medium were purchased from Clonetics (San Diego, CA). Recombinant human TNF-{alpha}, IL-1R antagonist (IL-1Ra), and neutralizing polyclonal anti-human TNF-{alpha} were obtained from Peprotech (Rocky Hill, NJ). Matched Ab pairs for the IL-8 ELISA were obtained from R&D Systems (Minneapolis, MN). The protease inhibitors leupeptin, chymostatin, pepstatin, antipain, bestatin, and Pefabloc SC and the transfection reagent FuGene were obtained from Boehringer Mannheim (East Sussex, U.K). Rabbit polyclonal Abs to p52, p65, Rel B, c-fos, and goat polyclonal Ab to p50 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Serotec (Oxford, U.K.) supplied c-rel rabbit polyclonal Ab. Rabbit Ig fraction (normal) for negative control (X0903) was purchased from Dako (Glostrup, Denmark). Ficoll-Paque was purchased from Pharmacia Biotech (Uppsala, Sweden). Hybond-N was purchased from Amersham (Little Chalfont, U.K.). Oligonucleotides were synthesized by Genosys Biotechnologies (Cambridge, U.K) and Oswell (Southampton, U.K.). Renilla luciferase control reporter vector pRL-TK and the reporter gene assay kit, Dual-Luciferase Reporter Assay System, were obtained from Promega (Madison, WI). All other chemical reagents were obtained from Sigma (Poole, U.K.).

Human cell culture

The human pulmonary type II alveolar epithelial A549 cell line (48) was purchased from European Collection of Animal Cell Cultures (no. 86012804) and maintained in DMEM supplemented with 10% FCS (containing endotoxin levels <0.02ng/ml), 2 mM glutamine, and 10 µg/ml ampicillin, an antibiotic with no significant antimycobacterial activity at this concentration, in a humidified 5% CO2 atmosphere. Epithelial cells were seeded in tissue culture plates 48 h before use. Immediately before experiments, medium was replaced with serum-free DMEM supplemented with 2 mM glutamine and 10 µg/ml ampicillin. As a primary cell correlate, normal human bronchial epithelial cells (NHBE) were used. These primary cells originate from the upper airway epithelium, in contrast to the alveolar epithelial cell line A549, which is derived from type II pneumocytes present in the alveoli. NHBE were maintained and seeded in bronchial epithelial growth medium (according to suppliers instructions).

Human peripheral blood monocytes were prepared from pooled buffy coats obtained from North Thames Blood Transfusion Service (Colindale, U.K). PBMCs were separated out by density gradient centrifugation on Ficoll-Paque, and monocytes were purified by adhesion to tissue culture plastic for 2 h. Monocytes were maintained in RPMI 1640 supplemented with 10% FCS, 2 mM glutamine, and 10 µg/ml ampicillin.

Mycobacterial culture

The virulent strain of M. tuberculosis H37-Rv (obtained from the National Collection of Type Cultures, Colindale, U.K) was used in all experiments. Stocks of these organisms were maintained in Dubos’ medium enriched with albumin Cohn fraction V plus dextrose and sodium chloride. Before use in experiments, 1 ml of a mid-logarithmic-phase mycobacterial suspension was briefly sonicated (20 s) to break up clumps, left to stand for 10 min, and the top 750 µl used. This method was shown to generate single-cell mycobacterial suspensions by using a modified Kinyoun method to stain suspensions. The amount of viable mycobacteria present was quantitated for each experiment by plating in triplicate serial dilutions of the prepared mycobacterial suspension on Middlebrook (7H10) plates (Royal Brompton Hospital, London, UK) and colony counting 4 wk later.

Epithelial cell and monocyte stimulation

A549 cells were grown to confluence on Thermanox cover slips (ICN Biomedicals, Cleveland, OH) in 35-mm petri dishes and exposed to M. tuberculosis (MOI = 1). After 1, 2, 4, 8, and 24 h, monolayers were washed and the coverslips air dried, heat and formaldehyde fixed, and stained using a modified Kinyoun stain. Microscopy was performed to determine the percentage of cells infected with M. tuberculosis by counting the number of epithelial cells associated with mycobacteria. Counts were performed in three high-power fields per slide for each time point, and the experiment performed in triplicate. We confirmed previously published data (26) demonstrating that M. tuberculosis was able to invade A549 cells over 24 h by invasion assays using amikacin to kill extracellular organisms, washing, and then lysing cell monolayers before culturing lysates on 7H10 plates, and colony counting mycobacterium 4 wk later.

Human peripheral blood monocytes were infected with M. tuberculosis (strain H37-Rv; MOI = 10) for 24 h, and the conditioned media (CoMTB) were harvested and stored at -70°C. Conditioned media from unstimulated human monocytes cultured for 24 h (CoMControl) was used as a negative control. Epithelial cells were exposed to M. tuberculosis (MOI = 1–10), CoMTB, CoMControl, or to the positive control TNF-{alpha} (20 ng/ml). The CoMTB was used at the dilutions 1:10, 1:100, and 1:1000, diluted in serum-free DMEM. In experiments where IL-1Ra was used, epithelial cells were preincubated for 2 h at 37°C before stimulation, and in those using neutralizing anti-TNF-{alpha} Ab, CoMTB was preincubated with the Ab for 1 h at 37°C before use. Anti-TNF-{alpha} (50 µg/ml) neutralizes 10 ng/ml of TNF-{alpha} (data supplied by manufacturer). We confirmed that 50 µg/ml anti-TNF-{alpha} abolished the ability of 10 ng/ml TNF-{alpha} to stimulate IL-8 release from A549 cells and to induce nuclear translocation of NF-{kappa}B in A549 cells.

RNA extraction and Northern blotting

Following aspiration of supernatant at specific time points, epithelial cell monolayers were washed in ice-cold PBS, homogenized in RNA extraction buffer (4 mM guanidine thiocyanate, 25 mM Tris, pH 7.0, 0.5% N-lauroylsarcosine, and 0.1 M 2-ME), and frozen at -70°C. RNA extraction was performed by a guanidium thiocyanate-phenol-chloroform extraction method modified from previously described protocols (25, 49). Aliquots (20 µg) of RNA were run on a denaturing formaldehyde 1% agarose gels, transferred by capillary blotting to Hybond-N, and fixed by exposure to UV light using a UV Stratalinker 1800 (Stratagene, La Jolla, CA).

Blots were prehybridized and then hybridized with [{gamma}-32P]-end-labeled oligonucleotide probes: IL-8 with a 33-mer probe and ß-actin with a 42-mer probe (50). ß-actin probing and assessment of 18S/28S ribosomal RNA (rRNA) bands on ethidium-stained gels were used to ensure uniform RNA loading. Blots were autoradiographed with intensifying screens at -70°C for 24–48 h. Autoradiograph images were digitized (Umax, Power Look II) and analyzed with NIH Image 1.52 (from National Institutes of Health Research Services Branch, Bethesda, MD). IL-8 signal densitometry was normalized for total RNA loading using ß-actin mRNA densitometry, except for mRNA decay studies when 18S/28S rRNA were used. Between probings, blots were stripped by heating for 1 h at 65°C in a solution of 0.005 M Tris-HCl, pH 8.0, 0.0002 M EDTA, and 0.1x Denhardt’s solution.

Cytokine assay

IL-8 was assayed in cell-culture supernatants by ELISA using matched Ab pairs according to the manufacturer’s instructions. The lower limit of sensitivity of the IL-8 ELISA was 15 pg/ml. IL-8 concentrations are expressed in pg/106 cells as mean ± SEM of three independent experiments.

Preparation of nuclear extracts

At the indicated time points, nuclear extracts from stimulated and control cells were prepared from 107 A549 cells using a modified version of a previously published protocol (51). In brief, cell monolayers were washed with PBS and then cytoplasmic extraction buffer (10 mM Tris-HCl, 60 mM KCL, 1 mM EDTA, 1 mM DTT) containing a mixture of protease inhibitors (leupeptin, E64, chymostatin, pepstatin, antipain, bestatin, and Pefabloc SC) applied for 10 min. Then, 0.15% Nonidet P-40 was added and the cell lysate was centrifuged at 500 x g for 5 min, and the resultant cell nuclei pellet was washed in cytoplasmic extraction buffer, pelleted, and then resuspended in nuclear extract buffer (20 mM Tris-HCl, pH 8.0, 400 mM NaCl, 1.5 mM MgCl2, 1.5 mM EDTA, 25% glycerol, 1 mM DTT, and the above protease inhibitors) and incubated on ice for 10 min. After centrifugation at 500 x g, the soluble nuclear extract was aspirated and stored at -70°C. Protein quantitation was performed spectrophotometrically at 590 mm using the Bradford assay (52) before storage.

EMSA

Nuclear extract (5 µg) was mixed with 0.7 ng [{gamma}-32P]-end-labeled double-stranded DNA probe with sp. act. >1 x 108 cpm/µg in DNA binding buffer containing 10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.25 mg/ml BSA, 3 µg poly(dI-dC), and 5% glycerol. The oligonucleotides used contained either the sequence specific for the IL-8 NF-{kappa}B binding site (-82GTGGAATTTCC-72) (42) or mutated NF-{kappa}B binding sequence (-82GaatAATTTCC-72). Bound and free probe were resolved on a 4% polyacrylamide gel containing 50 mM Tris, 0.38 M glycine, and 2 mM EDTA. Gels were dried and autoradiographed at -70°C overnight with intensifying screens. Probe binding specificity was demonstrated by competition assays using up to a 25-fold excess of cold, unlabeled probe specific for the IL-8 NF-{kappa}B-binding region and by failure to compete out the signal with a 25-fold excess of unlabeled mutated probe. Supershift assays were performed using 1 µg of Abs to the NF-{kappa}B subunits p50, p52, p65, Rel B, and c-rel or to c-fos (a subunit of the unrelated transcription factor, AP-1). These were added to the binding mix and incubated for 15 min at room temperature before running on a 4% polyacrylamide gel.

Transfections and luciferase assays

Three promoter-reporter constructs of the 5' flanking region (-1370 to +82) of the IL-8 gene (a generous gift of Dr. W. Reed, Environmental Protection Agency, Chapel Hill, NC) were used. One construct contained wild-type NF-{kappa}B and NF-IL-6 binding sites (WT), one a mutated NF-{kappa}B binding site ({Delta}NF-{kappa}B), and one a mutated NF-IL-6 binding site ({Delta}NF-IL-6). These constructs had been inserted into the firefly luciferase expression plasmid PGL2-basic. Plasmid DNA was purified from the Escherichia coli host using Qiagen plasmid kits according to manufacturers instructions (Qiagen, Chatsworth, CA).

For transfection studies, A549 cells were grown to 50% confluence in 35-mm petri dishes. Cells were then transfected using FuGene 6, a lipid formulation. Then, 5 µg of the required IL-8 promoter-reporter gene was cotransfected with 0.25 µg of a control reporter plasmid PRL-TK, which constitutively expresses low-level Renilla luciferase, and left overnight (16 h). Following stimulation with CoMTB for 2 h, cell extracts were harvested by first washing the monolayer in PBS and then manually scraping the cells from the culture dishes in the presence of passive lysis buffer (Promega, Madison, WI). Cell extracts were stored at -70°C. Firefly and Renilla luciferase activity was later measured in cell extracts using the Dual-Luciferase Reporter Assay System using a luminometer Bio-Orbit 1253 (Labtech International, East Sussex, U.K.). Measurement of Renilla luciferase activity was used to normalize experimental firefly luciferase values and control for variability in transfection efficiency. The WT IL-8 promoter-reporter gene luciferase activity in response to CoMTB stimulation was expressed as maximal luciferase activity (100%). WT IL-8 promoter-reporter gene activity in response to CoMControl, and mutated IL-8 promoter-reporter gene activity in response to CoMTB, were expressed as a percentage of this maximum.

Analysis and presentation of data

Results of ELISAs are expressed as pg/106 cells, means ± SEM of at least three independent experiments. Luciferase assays are expressed as percentage maximal luciferase activity, means ± SEM of at least three independent experiments, each of which were performed in triplicate. Northern blots (together with a computerized, densitometric analysis taking into account total RNA loaded) and EMSA are shown, representative of at least three independent experiments.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
M. tuberculosis-stimulated secretion of IL-8 from A549 cells and human monocytes

The percentage of A549 cells infected with M. tuberculosis (strain H37-Rv, MOI 1), assessed by microscopy of Kinyoun-stained cell preparations, showed that 15.8 ± 1.3% (mean ± SEM) of A549 cells were infected at 1 h, 33.4 ± 1.5% at 2 h, 31.3 ± 0.9% at 4 h, and 60.1 ± 5.4% at 8 h with no significant increase by 24 h. This is consistent with a study demonstrating by invasion assays that 41 ± 4% of A549 cells were invaded by M. tuberculosis strain H37-Rv (MOI = 1) after 2 h incubation (26).

A549 cells were exposed to M. tuberculosis (strain H37-Rv; MOI = 10), and IL-8 was measured in cell-culture supernatants by ELISA over a 24-h period. At this MOI, no significant A549 cell cytotoxicity occurs over a 24-h incubation (28). Increased IL-8 secretion was detected in cell-culture supernatants after 4 h and rose to a maximal level of 7720 ± 930 pg/106epithelial cells by 24 h (Fig. 1GoA). The positive control TNF-{alpha} (20 ng/ml) stimulated IL-8 secretion within 1 h, which rose to 17,700 ± 5,200 pg/106 cells by 24 h, levels consistent with previous reports (22, 47). M. tuberculosis at a lower, more pathophysiological MOI also stimulated IL-8 secretion from A549 cells in a dose-dependent manner. At an MOI of 1 and 0.1, IL-8 concentrations were 1600 ± 367 pg/106cells and 943 ± 207 pg/106cells, respectively, at 24 h (Fig. 1GoB). In contrast, the levels of IL-8 secretion from M. tuberculosis-infected human monocytes were much greater and reached 184,100 ± 3,100 pg/106 monocytes after 24 h, levels similar to previous studies (12, 25) (Fig. 1GoC). Such levels were 25-fold more than those observed from pulmonary epithelial cells directly infected with M. tuberculosis.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1. M. tuberculosis-induced IL-8 secretion from A549 cells and human monocytes. A, A549 cells were infected with M. tuberculosis (strain H37-Rv; MOI = 10), TNF-{alpha} 20 ng/ml, or exposed to media alone. Cell-culture supernatants were harvested at 0, 1, 2, 4, 8, and 24 h following infection and IL-8 protein measured by ELISA. Results are the mean ± SEM of three independent experiments. B, A549 cells were infected with M. tuberculosis (strain H37-Rv) at MOI = 1, MOI = 0.1, or exposed to media alone. Cell-culture supernatants were harvested and assayed for IL-8 levels as above. C, Human peripheral blood-derived monocytes were infected with M. tuberculosis, (strain H37-Rv; MOI = 10) for 24 h or left unstimulated. IL-8 levels were measured in the monocyte cell-culture supernatants by ELISA. Results are the mean ± SEM of three independent experiments.

 
CoMTB-induced secretion of IL-8 from A549 cells

To determine whether phagocytosis of M. tuberculosis may have indirect effects on pulmonary epithelial cell IL-8 secretion, we used conditioned media, harvested from human peripheral blood-derived monocytes infected for 24 h with M. tuberculosis, to stimulate A549 cells. This CoMTB was used to stimulate A549 cells over a 24-h period at dilutions of 1:10, 1:100, and 1:1000 in serum-free DMEM and IL-8 measured in cell-culture supernatants by ELISA. CoMControl was used as the negative control at a 1:10 dilution. Monocyte-derived IL-8 present in the CoMTB is represented by the baseline IL-8 measured at t = 0. Taking this baseline into account, A549 cells stimulated with CoMTB, at a dilution of 1:10, secreted 23,050 ± 1,220 pg/106 cells of IL-8 within 4 h, and 92,635 ± 13,180 pg/106 cells after 24 h incubation (Fig. 2Go). The CoMTB-induced IL-8 secretion at 24 h was 12-fold greater than that following direct exposure of epithelial cells to M. tuberculosis (92,635 ± 13,180 pg/106 cells vs 7,720 ± 930 pg/106 cells) and 5-fold higher than following stimulation with TNF-{alpha} (20 ng/ml) (Fig. 1GoA). CoMTB was a potent stimulus, as even a dilution of 1:100 induced 14,630 ± 3,865 pg/106 cells of IL-8 after 8 h, and low level secretion was evident with a 1:1000 dilution of CoMTB. These data indicate that IL-8 secretion from CoMTB-stimulated pulmonary epithelial cells is much greater than that following direct infection of cells with M. tuberculosis and of a similar order of magnitude to that secreted by M. tuberculosis-infected human monocytes.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 2. Kinetics of CoMTB-induced IL-8 secretion from A549 cells. CoMTB was used to stimulate pulmonary epithelial cells over a 24-h period at dilutions of 1:10, 1:100, and 1:1000, in serum-free DMEM. CoMControl was used to stimulated pulmonary epithelial cells over 24 h at a dilution of 1:10 in serum-free DMEM. IL-8 was measured in the cell-culture supernatants at 0, 1, 2, 4, 8, and 24 h following stimulation with CoMTB or CoMControl and expressed as mean ± SEM of three independent experiments. IL-8 measured at t = 0 represents monocyte-derived IL-8 present in CoMTB.

 
CoMTB induces early, stable IL-8 mRNA accumulation in A549 cells

IL-8 mRNA, assessed by Northern analysis, was not detected in A549 cells stimulated by CoMControl but appeared within 1 h of stimulation with CoMTB, peaked between 2–4 h, and persisted 24 h poststimulation (Fig. 3Go). These kinetics of IL-8 gene expression are consistent with the IL-8 protein secretion. There was a clear dose-response effect of CoMTB on IL-8 mRNA accumulation over the 3 log-fold dilutions investigated. Strong expression of IL-8 mRNA expression was evident at 24 h and suggested either continued IL-8 gene transcription or posttranscriptional stabilization of IL-8 mRNA. Because evidence exists that a number of cytokines are posttranscriptionally modified to increase mRNA stability (53), this possibility was investigated in transcriptional blockade studies. The RNA polymerase II inhibitor actinomycin D (10 µg/ml) was added to A549 cell cultures 2 h after stimulation by either CoMTB, CoMControl, or TNF-{alpha} 20 ng/ml, at which time significant IL-8 mRNA accumulation had occurred. Cells were harvested for RNA extraction and Northern analysis 1, 2, 4, 8, and 24 h later. Nearly 70% of the baseline IL-8 mRNA signal from CoMTB-stimulated cells was still detectable 24 h after inhibition of new gene transcription (Fig. 4GoA). In contrast, in TNF-{alpha}-stimulated cells IL-8 mRNA decayed rapidly, falling to 30% of baseline signal within 1 h and was barely detectable 8 h after the addition of actinomycin D (Fig. 4GoB). CoMControl-stimulated cells showed no IL-8 mRNA accumulation both before or after actinomycin D (Fig. 4GoC). These results indicate that CoMTB induces in a dose-dependent manner an early, specific up-regulation of IL-8 mRNA, which is posttranscriptionally regulated to cause mRNA stabilization.



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 3. CoMTB induced early IL-8 mRNA accumulation in A549 cells over 24 h. IL-8 mRNA accumulation from CoMTB-stimulated cells (stimulated as described in Fig. 2Go) was assessed by Northern analysis at 0, 1, 2, 4, 8, and 24 h poststimulation. Equal loading of total RNA was ensured by UV visualization of ethidium stained 18S/28S ribosomal RNA bands and by reprobing the same Northern blots for the housekeeping gene ß-actin. The graph shows densitometry of IL-8 mRNA, normalized for total RNA loading using ß-actin densitometry. Shown is a representative autoradiograph and densitometric analysis of three independent experiments.

 


View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 4. Differences in IL-8 mRNA stability in A549 cells following stimulation by CoMTB or by TNF-{alpha}. A549 cells were stimulated at t = -2 for 2 h with (A) CoMTB, (B) TNF-{alpha} 20 ng/ml, and (C) CoMControl. Actinomycin D 10 µg/ml was added to the cell culture media at t = 0 to inhibit new gene transcription. Total RNA was harvested for each stimulus at the time points indicated and used for Northern analysis for detection of IL-8 mRNA over the following 24 h. Densitometry of IL-8 mRNA signals was normalized for total RNA loading using 18S/28S ribosomal RNA bands. Shown is an autoradiograph and densitometric analysis representative of three independent experiments.

 
Activation of NF-{kappa}B in CoMTB-stimulated A549 cells

To investigate the mechanisms underlying IL-8 gene activation in response to CoMTB, we analyzed the role of the transcriptional regulator NF-{kappa}B in the control of IL-8 gene expression in pulmonary epithelial cells. Nuclear extracts prepared from A549 cells stimulated by CoMTB or CoMControl for 1, 2, 4, 8, and 24 h were analyzed by EMSA for the presence of NF-{kappa}B using double-stranded oligonucleotides corresponding to the {kappa}B binding site in the IL-8 promoter region. CoMTB stimulated a high level of NF-{kappa}B nuclear binding, which was clearly present at 1 h and maintained at 4 h (Fig. 5GoA). Such a time course of NF-{kappa}B binding was consistent with the kinetics of IL-8 gene expression. No NF-{kappa}B activation was seen following exposure to CoMControl, but NF-{kappa}B translocation (without NF-IL-6 activation) was observed in the TNF-{alpha}-stimulated control cells (data not shown and consistent with published literature (47)). The NF-{kappa}B binding due to CoMTB was a specific effect, competed out in a dose-dependent manner by a 25-fold excess of cold oligonucleotide probe, but not competed out with a 25-fold cold excess of an oligonucleotide containing a mutated NF-{kappa}B binding site (Fig. 5GoB).



View larger version (30K):
[in this window]
[in a new window]
 
FIGURE 5. Activation of NF-{kappa}B in CoMTB-stimulated A549 cells. A, Nuclear extracts from A549 cells stimulated by either by CoMTB or by CoMControl. Nuclear extracts were mixed with a [{gamma}-32P]-end-labeled double-stranded oligonucleotide probe specific for the IL-8 NF-{kappa}B binding site and analyzed on a 4% polyacrylamide gel as described in Materials and Methods. B, Competition experiments were performed on nuclear extracts harvested from CoMTB-stimulated A549 cells after 1 h incubation. In lane 2, a 5-fold excess of unlabeled probe partially competed out the NF-{kappa}B binding signal due to labeled probe, and in lane 3, a 25-fold excess of unlabeled probe has competed out virtually all NF-{kappa}B binding to labeled probe. In lane 4, a 25-fold excess of the mutated cold probe failed to compete out NF-{kappa}B binding to labeled probe. C, Supershift analysis to investigate specific subunit involvement in CoMTB-stimulated NF-{kappa}B binding in the nucleus of A549 cells. Nuclear extracts harvested at 1 h poststimulation were mixed with [{gamma}-32P]-end-labeled double-stranded oligonucleotide specific for the IL-8 NF-{kappa}B binding site and then incubated for 15 min with an Ab to the NF-{kappa}B subunits p65, c-Rel, p50, p52, and RelB and to the c-fos subunit of AP-1 (an irrelevant Ab). Evidence of supershifting bands were visualized by EMSA.

 
Supershift assays on extracts harvested 1 h after exposure to CoMTB revealed that the major NF-{kappa}B subunits involved were p65, p50, and c-rel (Fig. 5GoC). There was no supershift related to either p52 or to Rel B subunits of NF-{kappa}B, and an irrelevant Ab to c-fos did not affect binding. Thus CoMTB activated nuclear translocation of three distinct subunits of NF-{kappa}B, including p50 and p65, which form the activating p50/p65 heterodimer.

CoMTB-activation of the IL-8 promoter is dependent on NF-{kappa}B and NF-IL-6 binding

Both NF-{kappa}B and NF-IL-6 have been shown to coregulate IL-8 gene expression (39, 40, 46), and therefore a promoter-reporter analysis was undertaken to investigate the effect of mutations of either of these transcription factor binding sites on the function of the IL-8 promoter in response to CoMTB stimulation. The three constructs used included most of the 5' flanking region of the IL-8 gene and contained either the WT NF-{kappa}B and NF-IL-6 binding sites or a mutated NF-{kappa}B with a WT NF-IL-6 binding site or a WT NF-{kappa}B with a mutated NF-IL-6 binding site inserted into a firefly luciferase expression plasmid (Fig. 6GoA). A549 cells were transfected with each of the IL-8 promoter-reporter genes, stimulated for 2 h by CoMControl or CoMTB, and luciferase activity was measured in cell extracts. NF-{kappa}B nuclear translocation had previously been demonstrated by EMSA at 2 h.



View larger version (20K):
[in this window]
[in a new window]
 
FIGURE 6. The effect of NF-{kappa}B and NF-IL-6 binding site mutations on the IL-8 promoter activity in response to CoMTB. A, Schematic representation of IL-8 promoter-reporter constructs showing nucleotide sequences of intact and mutated NF-{kappa}B and NF-IL-6 binding sites. Shown is the region of the IL-8 gene (-1370 to +82 bp) inserted upstream of the luciferase gene. The WT nucleotide sequence for the NF-{kappa}B (-91 to -84) and NF-IL-6 (-82 to -72) binding sites are represented in capitals, and the mutated sequences are in lower case. B, A549 cells at 50% confluence were transfected with 5 µg of a firefly luciferase expression plasmid (PGL2-basic) containing either the WT NF-{kappa}B and NF-IL-6 binding sites in the IL-8 promoter or a mutated NF-{kappa}B and WT NF-IL-6 binding site ({Delta}NF-{kappa}B) or a WT NF-{kappa}B binding site and mutated NF-IL-6 binding site ({Delta}NF-IL-6). Cells were cotransfected with 0.25 µg of a control expression plasmid (pRL-TK) providing a low-level constitutive expression of Renilla luciferase used for assessment of transfection efficiency. Transfected cells were stimulated with CoMTB or CoMControl for 2 h, and cell extracts were harvested and assayed for firefly and Renilla luciferase luminescence in the same sample. Firefly luciferase activity was normalized for transfection efficiency using Renilla luciferase levels. Luminescence from CoMTB-stimulated A549 cells transfected with the WT promoter expression plasmid is represented as maximal luciferase activity (100%), and all other results are expressed as a percentage of this maximum. Results are shown as mean ± SEM of three independent experiments, and each experiment was performed in triplicate.

 
The results show (Fig. 6GoB) that mutations of the NF-{kappa}B binding site in the IL-8 promoter caused luciferase activity to fall to 11.0 ± 1.4% of WT promoter activity, levels lower than that measured from CoMControl-stimulated cells (15.2 ± 3.7%). This demonstrated that NF-{kappa}B binding was absolutely necessary for activation of the IL-8 promoter in response to CoMTB. NF-IL-6 binding site mutations resulted in a reduction of luciferase activity to 50.2 ± 6.3% of WT promoter activity and suggest that, in contrast to NF-{kappa}B, NF-IL-6 is involved in but is not absolutely required for IL-8 activation in response to CoMTB.

Monocyte-derived IL-1 is essential for IL-8 production by CoMTB-stimulated A549 cells

To determine which specific mediators may mediate the effects of CoMTB on pulmonary epithelial cells, we investigated the role of two proinflammatory cytokines, TNF-{alpha} and IL-1, by using neutralizing polyclonal anti-human TNF-{alpha} Ab and IL-1Ra, the naturally occurring competitive inhibitor of IL-1 bioactivity (54). Both TNF-{alpha} and IL-1 are known to activate pulmonary epithelial cell IL-8 secretion (22) and are released by M. tuberculosis-infected monocytes (55, 56).

TNF-{alpha} 10 ng/ml stimulated IL-8 secretion from A549 cells, and we demonstrated that preincubation for 1 h of 10 ng/ml TNF-{alpha} with 50 µg/ml of human neutralizing anti-TNF-{alpha}, but not with an isotype-matched negative control Ig, completely inhibited IL-8 secretion from A549 cells at 24 h (Table IGo). This confirmed the neutralizing capability of the Ab and that its bioactivity was in accordance with the manufacturers data. The initial concentrations of anti-TNF-{alpha} of 1, 2, 5, and 10 µg/ml used to neutralize the TNF-{alpha} bioactivity in CoMTB did not inhibit IL-8 mRNA accumulation in CoMTB-stimulated A549 cells (Fig. 7GoA). The monocytes that had phagocytosed M. tuberculosis for 24 h secreted 2.9 ng/ml TNF-{alpha} into CoMTB, levels consistent with previous reports (25, 57). However, CoMTB was used after 10-fold or greater dilutions, making its final TNF-{alpha} concentration <300 pg/ml. This TNF-{alpha} concentration is much lower than that used as a positive control, which stimulated 6-fold less IL-8 secretion after 24 h (Fig. 1GoA) and 60% less IL-8 mRNA accumulation after 2 h (Fig. 4Go, A and B) than did CoMTB. This indicated that the TNF-{alpha} present in CoMTB was insufficient to account for the IL-8 secretion.


View this table:
[in this window]
[in a new window]
 
Table I. Neutralization of TNF-{alpha}-induced IL-8 secretion from A549 cells by preincubation with anti-TNF-{alpha}1

 


View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 7. Effect of increasing concentrations of IL-1Ra or of neutralizing anti-human TNF-{alpha} on IL-8 mRNA accumulation in CoMTB-stimulated A549 cells. A, CoMTB was preincubated for 1 h at 37°C alone or with increasing concentrations of polyclonal neutralizing anti-human TNF-{alpha} Ab and used to stimulate A549 cells for 2 h. Total RNA was harvested and used to assess cellular IL-8 mRNA accumulation by Northern analysis. A representative experiment is shown demonstrating IL-8 mRNA signal densitometry, which has been normalized for total RNA loading using ß-actin mRNA densitometry. B, A549 cells were preincubated for 2 h with increasing doses of IL-1Ra before stimulation with CoMTB for 2 h. IL-8 mRNA accumulation was assessed by Northern analysis as described above.

 
In contrast, preincubating A549 cells with up to 200 ng/ml IL-1Ra resulted in a dose-dependent inhibition of IL-8 gene expression, with only a small residual mRNA signal remaining at the highest concentration of IL-1Ra (Fig. 7GoB). Following this observation, the effect of anti-TNF-{alpha} (50 µg/ml, capable of neutralizing 10 ng/ml of TNF-{alpha}) and IL-1Ra (200 ng/ml), both alone and in combination on IL-8 secretion, mRNA accumulation, and NF-{kappa}B nuclear binding to IL-8 {kappa}B-binding sites, was determined (Fig. 8Go). IL-1Ra completely blocked IL-8 secretion from CoMTB-stimulated A549 cells to background levels, while anti-TNF-{alpha} had no effect (Fig. 8GoA). IL-1Ra treatment of A549 cells decreased IL-8 mRNA accumulation significantly from 93.7 ± 5.5% to 22.8 ± 2.1% (mean normalized densitometry ± SEM), while anti-TNF-{alpha} alone had no effect. In combination (Fig. 8GoB, lane 5), anti-TNF-{alpha} and IL-1Ra decreased IL-8 gene expression to 8.7 ± 2.1%, down to levels similar to those observed with CoMControl (6.3 ± 1.2%). The effect of IL-1Ra and anti-TNF-{alpha} on NF-{kappa}B nuclear binding was similar, with IL-1Ra almost completely inhibiting binding activity (Fig. 8GoC). These data demonstrate that IL-1 is the essential constituent of CoMTB, which mediates NF-{kappa}B-dependent IL-8 gene expression and secretion in pulmonary epithelial cells.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 8. Effects of IL-1Ra and neutralizing anti-human TNF-{alpha}, alone and in combination, on IL-8 secretion, mRNA accumulation, and on nuclear translocation of NF-{kappa}B in CoMTB-stimulated A549 cells. A549 cells were stimulated with CoMControl (lane1), CoMTB (lane2), CoMTB after the A549 cells had been preincubated with IL-1Ra 200 ng/ml for 2 h (lane 3), CoMTB that had been preincubated with neutralizing anti-TNF-{alpha} (50 µg/ml) (lane 4), and finally CoMTB that had been preincubated with neutralizing anti-TNF-{alpha} (50 µg/ml) and after the A549 cells had been preincubated with IL-1Ra 200 ng/ml for 2 h (lane 5). A, IL-8 secretion from cell-culture supernatants measured by ELISA after 24 h of stimulation by CoMTB. Data is expressed as mean ± SEM. B, IL-8 mRNA accumulation assessed by Northern analysis after 2 h of stimulation by CoMTB. An autoradiograph (representative of three independent experiments) is shown, with mean ± SEM densitometric analysis of the IL-8 mRNA signal normalised for total RNA loading using ß-actin mRNA densitometry. C, Nuclear translocation of NF-{kappa}B demonstrated after 1 h of stimulation by CoMTB. Nuclear extracts were mixed with a [{gamma}-32P]-end-labeled double-stranded oligonucleotide specific for the IL-8 NF-{kappa}B binding site and analyzed by EMSA.

 
Secretion of IL-8 from NHBE following infection with M. tuberculosis or stimulation by CoMTB

It was important to confirm that the IL-8 secretion from the cell line A549 was reproducible in primary lung epithelial cells. NHBE are a readily available source of such cells and are widely used as a primary cell correlate (54, 58, 59). NHBE originate from the upper airway epithelium, in contrast to the type II alveolar epithelial cell line A549, which is derived from type II pneumocytes found in the alveoli. Direct infection of NHBE by M. tuberculosis (MOI = 10) did not stimulate IL-8 secretion (Fig. 9GoA), in contrast to direct infection of the A549 cell line. However, CoMTB at a dilution of 1:10 stimulated significant IL-8 secretion from the primary epithelial cells (Fig. 9GoB). CoMControl resulted only in low-level constitutive IL-8 secretion from NHBE. Taking baseline monocyte-derived IL-8 secretion into account, NHBE secreted 2798 ± 796 pg/106 cells of IL-8 at 8 h and 13,416 ± 3,529 pg/106 cells after 24 h stimulation by CoMTB. We also confirmed in primary cells that IL-1Ra blocked the ability of CoMTB to stimulate IL-8 secretion, while anti-TNF-{alpha} had no inhibitory effect (Fig. 9GoC). These results show that CoMTB but not direct infection stimulates IL-8 secretion from pulmonary epithelial cells, an effect that is IL-1 mediated.



View larger version (14K):
[in this window]
[in a new window]
 
FIGURE 9. IL-8 secretion from NHBE following infection with M. tuberculosis and stimulation by CoMTB. A, NHBE were infected with M. tuberculosis (strain H37-Rv; MOI = 10) or exposed to media alone. Cell-culture supernatants were harvested at 0, 8, and 24 h following infection and IL-8 concentrations measured by ELISA. Results are the mean ± SEM of three experiments. B, Kinetics of CoMTB-induced IL-8 secretion from NHBE. CoMTB and CoMControl were used to stimulate NHBE over a 24-h period at dilutions of 1:10 in bronchial epithelial growth medium. IL-8 was measured in the cell-culture supernatants at 0, 8, and 24 h after stimulation and are expressed as mean ± SEM of three independent experiments. IL-8 measured at t = 0 represents monocyte-derived IL-8 present in CoMTB. C, Effects of preincubation with IL-1Ra (200 ng/ml) and neutralizing anti-human TNF-{alpha} (50 µg/ml), alone and in combination, on IL-8 secretion from NHBE stimulated by CoMTB (1:10 dilution). Supernatants were harvested for ELISA measurement of IL-8 at 24 h. Data are expressed as mean ± SEM of three independent experiments.

 
Role of IL-1ß in secretion of IL-8 from NHBE and A549 cells

Because IL-1Ra inhibited IL-8 secretion from epithelial cells stimulated by CoMTB, we investigated whether recombinant IL-1ß stimulated IL-8 secretion from A549 cells and NHBE. IL-1ß 2 ng/ml stimulated A549 cells to secrete 75,917 ± 3,444 pg IL-8/106 cells after 24 h, which was inhibited by preincubation with a 100-fold excess IL-1Ra (Fig. 10GoA). Similar findings were observed in IL-1ß-stimulated NHBE, which secreted 15,354 ± 4,564 pg IL-8/106 cells at 24 h (Fig. 10GoB), concentrations similar to those secreted by NHBE stimulated with CoMTB. Effects of IL-1ß on NHBE were inhibited by IL-1Ra. These data confirm a central role for IL-1 as the active constituent of CoMTB. However, blocking the activity of any autologous IL-1 by IL-1Ra did not alter IL-8 secretion from A549 cells directly infected by M. tuberculosis, indicating that IL-1 is not implicated in this aspect of IL-8 secretion (Fig. 10GoC).



View larger version (11K):
[in this window]
[in a new window]
 
FIGURE 10. IL-1ß and the control of IL-8 secretion from NHBE and A549 cells. A549 cells (A) and NHBE (B) were either left unstimulated for 24 h (lane 1) or stimulated by IL-1Ra 200 ng/ml alone for 24 h (lane 2) or stimulated either by recombinant IL-1ß 2 ng/ml alone (lane 3) or by IL-1ß 2 ng/ml after a 2 h epithelial cell preincubation with IL-1Ra 200 ng/ml (lane 4). IL-8 was measured by ELISA in the cell-culture supernatant. Results are mean ± SEM of three experiments. C, To investigate possible effects of autologous IL-1ß secretion on IL-8 release by A549 cells directly infected with M. tuberculosis (MOI = 1,) cells were cultured with M. tuberculosis for 24 h alone or after preincubation with IL-1Ra 200 ng/ml. IL-8 was measured in the cell-culture supernatant, and the results shown are the mean ± SEM of three experiments.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study, we demonstrate a major, previously unsuspected role for human alveolar epithelial cells in chemokine secretion during host defense to M. tuberculosis, which is the secretion of high concentrations of IL-8 as a result of a cytokine network activated by monocyte phagocytosis of M. tuberculosis. Previous studies have demonstrated that the alveolar epithelium can actively participate in host immune response by cytokine and chemokine production in response to both pathogens (17, 18, 20) and proinflammatory cytokines (21, 22, 23, 24, 60). We have demonstrated that direct infection of A549 cells with M. tuberculosis causes low-level IL-8 secretion, a response not detected in primary NHBE. In marked contrast, CoMTB caused substantial up-regulation of epithelial cell IL-8 secretion. CoMTB stimulated IL-8 secretion from A549 cells, which occurred within 4 h and was 12-fold greater than that following direct infection by M. tuberculosis. CoMTB had a similar effect on NHBE, causing secretion of high concentrations of IL-8 (13,416 ± 3,529 pg/106 cells by 24 h). Therefore, CoMTB and not direct infection is the major stimulus to pulmonary epithelial cell IL-8 secretion during infection with tuberculosis.

Alveolar macrophages and monocytes, recruited early in the course of pulmonary infection with M. tuberculosis, have previously been considered the major cellular source of immunoregulatory and proinflammatory mediators, including chemokines, in the lung (12, 25, 61, 62). However, our data suggest that although phagocytosis of M. tuberculosis by monocytes and macrophages may initiate host immune defenses by cytokine production, pulmonary epithelial cells subsequently have a pivotal role. Such epithelial IL-8 secretion is likely to be an early feature of the immune response to M. tuberculosis because IL-8 mRNA accumulation was detectable within 1 h. Furthermore, CoMTB caused significant IL-8 gene expression and secretion from pulmonary epithelial cells even at large dilutions. Thus even in the earliest stages of infection, when relatively few monocytic cells will have phagocytosed M. tuberculosis, there will be a significant release of IL-8 from the alveolar epithelium, stimulating early recruitment of neutrophils and T lymphocytes. The vast surface area of the pulmonary epithelium suggests that this is likely to be a major cellular source of IL-8 in host defense in pulmonary tuberculosis.

We observed that direct infection of A549 cells with M. tuberculosis stimulated A549 cells to secrete low IL-8 concentrations within 8 h. These kinetics of IL-8 secretion were consistent with the time required for M. tuberculosis infection to become established within A549 cells, which we and others have found to occur within 4–8 h (26). IL-8 secretion from infected A549 cells varied with MOI, and was detected even at a low pathophysiological MOI. IL-8 secretion by epithelial cells is pathogen specific; for example, respiratory syncytial virus-stimulated IL-8 release from alveolar epithelial cells occurs rapidly, within 2 h of infection, and in high concentrations (17). Our results with A549 cells are in keeping with a recent study that reported that M. tuberculosis was able to directly stimulate low-level secretion of both IL-8 and monocyte chemoattractant protein-1 but not of macrophage inflammatory protein-1 {alpha}ß or RANTES in pulmonary epithelial cells over a period of 1–6 days (29). However, when we investigated IL-8 secretion from primary pulmonary epithelial cells directly infected with M. tuberculosis, we found no release of this chemokine. Therefore, direct exposure of the alveolar epithelium to virulent mycobacteria does not appear to be a significant source of IL-8 in pulmonary tuberculosis.

Epithelial cell IL-8 mRNA accumulation activated by CoMTB was not only rapid but stable over a 24-h period. Almost 70% of IL-8 mRNA persisted 24 h after inhibition of new gene transcription by actinomycin D. This was a specific response to CoMTB because we and others have found that <25% of IL-8 mRNA accumulated following TNF-{alpha} stimulation of A549 cells remains detectable by Northern analysis 4 h after blocking transcription with actinomycin D (60). Posttranscriptional regulatory mechanisms that increase mRNA stability are critical in regulating gene expression of a number of cytokines (53). Mechanisms mediating mRNA stability involve conserved AU-rich sequences within the 3' untranslated region of the gene (63, 64) and such AU-rich regions are found in IL-8 mRNA. It is possible that persistent mRNA is a characteristic finding of chronic infection such as tuberculosis. CoMTB-stimulated pulmonary epithelial cells are probably not the only source of persistent IL-8 secretion because human monocytic cells phagocytosing M. tuberculosis secreted high IL-8 concentrations for 5 days (25).

IL-8 gene activation in response to CoMTB stimulation of alveolar epithelial cells was regulated by NF-{kappa}B. This transcription factor exists in the cytoplasm as a family of at least five rel-related subunits; p65, p50, p52, c-rel, and Rel B, which have varied stimulatory and inhibitory effects on promoter regions of different genes. The commonest activating heterodimer of NF-{kappa}B is comprised of p50/p65 (43), and we have previously demonstrated that it is this heterodimer that is activated in pulmonary epithelial cells after infection with replicating respiratory syncytial virus (59). In the present study, the kinetics of NF-{kappa}B activation in CoMTB-stimulated epithelial cells showed nuclear translocation over a 4-h period, consistent with the kinetics of IL-8 mRNA accumulation. Studies of the transcriptional control of the IL-8 gene suggest that gene activation is differentially regulated by various combinations of NF-{kappa}B subunits in a cell type- and stimulus-specific fashion (41, 47, 65) and often involves cooperative interactions with other transcription factors (40, 66). In PMA-treated Jurkat T cells, p65 was the major subunit involved in regulation of the IL-8 promoter, and the subunit p50 was shown not to be involved (41). This may reflect an isolated interaction of the p65 subunit with {kappa}B-binding sites, or that p65 may be able to interact with other transcription factors. In contrast, in TNF-{alpha}-stimulated HeLa cells, p65 and to a lesser extent c-Rel, p50, and p52 subunits were all activated to regulate the IL-8 promoter (40). Recently, TNF-{alpha}-stimulated alveolar epithelial cells were shown to induce p65 binding by supershift assay, and p50 and c-Rel binding were only demonstrable by a highly sensitive two-step microaffinity isolation/Western immunoblot DNA binding assay (47). Our study showed a similar pattern of NF-{kappa}B subunit translocation to the nucleus, but p50, c-Rel, and p65 subunit binding were all readily detectable on supershift analysis. The transient transfection assays we performed confirmed NF-{kappa}B to be essential for activation of the IL-8 promoter in response to CoMTB as mutation of the NF-{kappa}B binding site abolished promoter-reporter gene activation. NF-IL-6 and NF-{kappa}B have been shown to exhibit synergistic and cooperative binding during regulation of the IL-8 gene (40, 46). We show that NF-IL-6 binding site mutation in the IL-8 promoter-reporter gene caused luciferase activity to fall to 50.2 ± 6.3% of WT in response to CoMTB. Therefore, NF-IL-6 contributes to but is not essential for IL-8 gene activation in this setting. These results are in contrast to TNF-{alpha}-stimulated A549 cells, where no role for NF-IL-6 was found (47), and demonstrate stimulus specificity in the mechanism of activation of IL-8 gene expression in pulmonary epithelial cells.

Monocytes phagocytosing M. tuberculosis secrete both IL-1ß and TNF-{alpha} (55, 56, 57), and both these cytokines are increased in BALF of patients with tuberculosis (67). We demonstrated that in CoMTB-mediated IL-8 secretion from epithelial cells, monocyte-derived IL-1 was absolutely necessary, whereas TNF-{alpha} was not. In contrast, in pulmonary networks activated by conditioned media from LPS-stimulated macrophages, IL-8 gene expression from A549 cells was reduced by 28 ± 7% with anti-TNF-{alpha} Ab, by 44 ± 8% with anti IL-1ß Ab, and by 83 ± 4% using both Abs together (22). Thus LPS and M. tuberculosis stimulate differing profiles of proinflammatory cytokine secretion from monocytic cells resulting in stimulus specificity for the effects of conditioned media on IL-8 secretion from epithelial cells. IL-1ß has been shown to induce IL-8 secretion from A549 cells within 4 h, increasing over 24 h of stimulation (22). We confirmed IL-1 to be the critical mediator of CoMTB by demonstrating that IL-1Ra abolished IL-8 secretion from A549 cells and NHBE, and inhibited IL-8 mRNA accumulation and nuclear binding of NF-{kappa}B. We also showed that recombinant IL-1ß could induce the same levels of IL-8 from both A549 and NHBE as CoMTB. NHBE secreted less IL-8 following the CoMTB stimulus than did A549 cells. Such reduced responses of primary epithelial cells compared with cell lines have been noted previously in response to TNF-{alpha} (60). In summary, IL-1 was absolutely required for the NF-{kappa}B-mediated IL-8 secretion from epithelial cells exposed to CoMTB, although blocking autologous IL-1 secretion did not decrease IL-8 secretion from directly infected A549 cells. The upstream events leading to NF-{kappa}B induction by IL-1ß are poorly understood, but may involve distinct signal transduction pathways in epithelial cells compared with other cell types (68).

This study has defined an important early role for pulmonary epithelial cells (which are present in large numbers in vivo) in the amplification of NF-{kappa}B-dependent, NF-IL-6-requiring IL-8 gene expression and secretion in response to cytokine networks established during infection with M. tuberculosis. Similar amplification cascades may also be important for other chemokines, such as RANTES, that have a central role in host defense to tuberculosis (69). Specifically, increased IL-8 secretion due to intercellular networks will result in neutrophil and T lymphocyte influx. Excess neutrophilic infiltration, a feature of many destructive lung diseases (70), may contribute to the debilitating loss of lung architecture often seen in pulmonary tuberculosis. This study implicates IL-1 as a critical mediator in immune response to pulmonary tuberculosis by its ability to induce IL-8 release from alveolar epithelial cells. Inhibiting the bioactivity of IL-1 effectively reduced IL-8 protein release, steady-state IL-8 mRNA accumulation, and nuclear translocation and binding to {kappa}B sites in the promoter of the IL-8 gene, suggesting potential future areas to target immunotherapeutic interventions.


    Acknowledgments
 
We thank Dr. William Reed (Environmental Protection Agency, Chapel Hill, NC) for providing the IL-8 promoter-reporter constructs and Dr. Eleni Stylianou (University of Nottingham, Nottingham, U.K) and Dr. Joanna Porter (Imperial Cancer Research Fund, London U.K.) for helpful advice.


    Footnotes
 
1 This work was supported by the Medical Research Council (U.K.). M.I.Y.W. is a Medical Research Council (U.K.) Training Fellow. L.H.T. and J.S.F. are supported by Action Research U.K. Back

2 Address correspondence and reprint requests to Dr. Jon S. Friedland, Department of Infectious Diseases, Imperial College, Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. E-mail address: Back

3 Abbreviations used in this paper: AP-1, activator protein 1; CoMControl, conditioned media from unstimulated human monocytes; CoMTB, conditioned media from M. tuberculosis-infected human monocytes; IL-1Ra, IL-1 receptor antagonist; MOI, multiplicity of infection; NHBE normal human bronchial epithelial cell; rRNA, ribosomal RNA; WT, wild type; BALF, bronchoalveolar lavage fluid. Back

Received for publication January 12, 1999. Accepted for publication July 21, 1999.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Murray, C. J. L., A. D. Lopez. 1997. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349:1269.[Medline]
  2. Baggiolini, M., B. Dewald, B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.[Medline]
  3. Walz, A., P. Peveri, H. Aschauer, M. Baggiolini. 1987. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149:755.[Medline]
  4. Yoshimura, T., K. Matsushima, J. J. Oppenheim, E. J. Leonard. 1987. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J. Immunol. 139:788.[Abstract]
  5. Schroeder, J. M., U. Mrowietz, E. Morita, E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin-1 activity. J. Immunol. 139:3474.[Abstract]
  6. Larsen, C. G., A. O. Anderson, E. Appella, J. J. Oppenheim, K. Matsushima. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464.[Abstract/Free Full Text]
  7. Gerszten, R. E., E. A. Garcia-Zepeda, Y. Lim, M. Yoshida, H. A. Ding, Jr M. A. Gimbrone, A. D. Luster, F. W. Luscinskas, A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398:718.[Medline]
  8. Wilkinson, P. C., I. Newman. 1992. Identification of IL-8 as a locomotor attractant for activated human lymphocytes in mononuclear cell cultures with anti-CD3 or purified protein derivative of Mycobacterium tuberculosis. J. Immunol. 149:2689.[Abstract]
  9. Larsen, C. G., M. K. Thomsen, B. Gesser, P. D. Thomsen, B. W. Deleuran, J. Nowak, V. Skodt, H. K. Thomsen, M. Deleuran, K. Thestrup-Pedersen, A. Harada, K. Matsushima, T. Menné. 1995. The delayed-type hypersensitivity reaction is dependent on IL-8 inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J. Immunol. 155:2151.[Abstract]
  10. Kurashima, K., N. Mukaida, M. Fujimura, M. Yasui, Y. Nakazumi, T. Matsuda. 1997. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Respir. Crit. Care 155:1474.[Abstract]
  11. Sadek, M. I., E. Sada, Z. Tossi, S. K. Schwander, E. A. Rich. 1998. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in the lung alveoli during active pulmonary tuberculosis. Am. J. Respir. Cell Mol. Biol. 19:513.[Abstract/Free Full Text]
  12. Zhang, Y., M. Broser, H. Cohen, M. Bodkin, K. Law, J. Reibman, W. N. Rom. 1995. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95:586.
  13. Bergeron, A., M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, P. Soler, A. Hance, A. Tazi. 1997. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159:3034.[Abstract]
  14. Friedland, J. S., J. C. Hartley, C. G. Hartley, R. J. Shattock, G. E. Griffin. 1995. Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 100:233.[Medline]
  15. Thurlbeck, W. M.. 1967. Internal surface area and other measurements in emphysema. Thorax 22:483.[Abstract/Free Full Text]
  16. Gaynor, C. D., F. X. McCormack, D. R. Voelker, S. E. McGowan, L. S. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155:5343.[Abstract]
  17. Fiedler, M. A., K. Wernke-Dollries, J. M. Stark. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:L865.[Abstract/Free Full Text]
  18. Subauste, M. C., D. B. Jacoby, S. M. Richards, D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of suceptibility to infection. J. Clin. Invest. 96:549.
  19. Naumann, M., S. Wessler, C. Bartsch, B. Wieland, T. F. Meyer. 1997. Neisseria gonorrhoeae epithelial cell interaction leads to the activation of the transcription factors nuclear factor {kappa}B and activator protein 1 and the induction of inflammatory cytokines. J. Exp. Med. 186:247.[Abstract/Free Full Text]
  20. DiMango, E., H. J. Zar, R. Bryan, A. Prince. 1995. Diverse Pseudomonas aeuroginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96:2204.
  21. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, R. M. Strieter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174:1355.[Abstract/Free Full Text]
  22. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945.
  23. Paine, R., M. W. Rolfe, T. J. Standiford, M. D. Burdick, B. J. Rollins, R. M. Strieter. 1993. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 150:4561.[Abstract]
  24. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, R. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J. Immunol. 155:410.[Abstract]
  25. Friedland, J. S., D. G. Remick, R. Shattock, G. E. Griffin. 1992. Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur. J. Immunol. 22:1373.[Medline]
  26. Bermudez, L. E., J. Goodman. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64:1400.[Abstract]
  27. Mehta, P. K., C. H. King, E. H. White, Jr J. J. Murtagh, F. D. Quinn. 1996. Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect. Immun. 64:2673.[Abstract]
  28. McDonough, K. A., Y. Kress. 1995. Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of Mycobacterium tuberculosis. Infect. Immun. 63:4802.[Abstract]
  29. Lin, Y., M. Zhang, P. F. Barnes. 1998. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66:1121.[Abstract/Free Full Text]
  30. Barnes, P. F., S. D. Mistry, C. L. Cooper, C. Pirmez, T. H. Rea, R. L. Modlin. 1989. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1114.[Abstract]
  31. Riedel, D. D., S. H. Kaufmann. 1997. Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan. Infect. Immun. 65:4620.[Abstract]
  32. Chertov, O., H. Ueda, L. Ling Xu, K. Tani, W. J. Murphy, J. Ming Wang, O. M. Zack Howard, T. J. Sayers, J. J. Oppenheim. 1997. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186:739.[Abstract/Free Full Text]
  33. Jones, G. S., H. S. Amirault, B. R. Anderson. 1990. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J. Infect. Dis. 162:700.[Medline]
  34. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPetro, V. M. Elner, S. G. Elner, R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798.[Abstract/Free Full Text]
  35. Peveri, P., A. Walz, B. Dewald, M. Baggiolini. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J. Exp. Med. 167:1547.[Abstract/Free Full Text]
  36. Clark-Lewis, I., C. Schumacher, M. Baggiolini, B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. J. Biol. Chem. 266:23128.[Abstract/Free Full Text]
  37. Chang, J. C., A. Wysocki, K. M. Tchou-Wong, N. Moskowitz, Y. Zhang, W. N. Rom. 1996. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51:306.[Abstract/Free Full Text]
  38. Hibbs, M. S., K. A. Hasty, J. M. Seyer, A. H. Kang, C. L. Minardi. 1985. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem. 260:2493.[Abstract/Free Full Text]
  39. Mukaida, N., Y. Mahe, K. Matsushima. 1990. Cooperative interaction of nuclear factor-{kappa}B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J. Biol. Chem. 265:21128.[Abstract/Free Full Text]
  40. Stein, B., Jr A. S. Baldwin. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-{kappa}B. Mol. Cell Biol. 13:7191.[Abstract/Free Full Text]
  41. Kunsch, C., C. A. Rosen. 1993. NF-{kappa}B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell Biol. 13:6137.[Abstract/Free Full Text]
  42. Mukaida, N., M. Shiroo, K. Matsushima. 1989. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 143:1366.[Abstract]
  43. Baeuerle, P. A., D. Baltimore. 1996. NF-kB: ten years after. Cell 87:13.[Medline]
  44. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, U. Siebenlist. 1995. Control of I{kappa}-Ba proteolysis by site-specific, signal induced phosphorylation. Science 267:1485.[Abstract/Free Full Text]
  45. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, P. Baeuerle. 1993. Rapid proteolysis of I{kappa}B-a is necessary for activation of transcription factor NF-{kappa}B. Nature 365:182.[Medline]
  46. Mastronarde, J. G., B. He, M. M. Monick, N. Mukaida, K. Matsushima, G. W. Hunninghake. 1996. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-{kappa}B and NF-IL-6. J. Infect. Dis. 174:262.[Medline]
  47. Brasier, A. R., M. Jalmaluddin, A. Casola, W. Duan, Q. Shen, R. P. Garofalo. 1998. A promoter recruitment mechanism for tumour necrosis factor-{alpha}-induced Interleukin-8 transcription in type II pulmonary epithelial cells. J. Biol. Chem. 273:3551.[Abstract/Free Full Text]
  48. Lieber, M., B. Smith, A. Szakal, W. Nelson-Rees, G. Todaro. 1976. A continuous tumour-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17:62.[Medline]
  49. Chomczynski, P., N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.[Medline]
  50. Strieter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF{alpha}, IL-1 and LPS. Science 243:1467.[Abstract/Free Full Text]
  51. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, E. G. Neilson. 1988. Characterisation of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell Biol. 8:1715.[Abstract/Free Full Text]
  52. Bradford, M. M.. 1976. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.[Medline]
  53. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.[Abstract/Free Full Text]
  54. Levine, S. J., T. Wu, J. H. Shelhamer. 1997. Extracellular release of the type 1 intracellular IL-1 receptor antagonist from human airway epithelial cells. J. Immunol. 158:5949.[Abstract]
  55. Wallis, R. S., M. Amir Tahmasseb, J. J. Ellner. 1990. Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc. Natl. Acad. Sci. USA 87:3348.[Abstract/Free Full Text]
  56. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1ß and tumor necrosis factor-{alpha} by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076.
  57. Fulton, S. A., J. V. Cross, Z. T. Tossi, W. H. Boom. 1998. Regulation of interleukin-12 by interleukin-10, transforming growth factor-ß, tumour necrosis factor-{alpha}, and interferon-{gamma} in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 178:1105.[Medline]
  58. Garofalo, R., F. Mei, R. Espejo, G. Ye, H. Haeberle, S. Baron, P. L. Ogra. 1996. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-ß and IL-1{alpha}. J. Immunol. 157:2506.[Abstract]
  59. Thomas, L. H., J. S. F. Friedland, M. Sharland, S. Becker. 1998. Respiratory syncitial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-{kappa}B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of {kappa}Ba. J. Immunol. 161:10071.
  60. Kwon, O. J., B. T. Au, P. D. Collins, I. M. Adcock, J. C. Mak, R. R. Robbins, K. F. Chung, P. J. Barnes. 1994. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. Am. J. Physiol. 267:L398.[Abstract/Free Full Text]
  61. Nicholson, S., M. da Glòria Bonecini-Almeida, J. Roberto Lapa e Silva, C. Nathan, Q. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Rom, J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183:2293.[Abstract/Free Full Text]
  62. Toossi, Z., P. Gogate, H. Shiratsuchi, T. Young, J. J. Ellner. 1995. Enhanced production of TGF-ß by blood monocytes from patients with active tuberculosis and presence of TGF-ß in tuberculous granulomatous lung lesions. J. Immunol. 154:465.[Abstract]
  63. Shaw, G., R. Kamen. 1986. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659.[Medline]
  64. Zubiaga, A. M., J. G. Belasco, M. E. Greenberg. 1995. The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell Biol. 15:2219.[Abstract]
  65. Garofalo, R., M. Sabry, M. Jamaluddin, R. K. Yu, A. Casola, P. L. Ogra, A. R. Brasier. 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J. Virol. 70:8773.[Abstract]
  66. Mastronarde, J. G., M. M. Monick, N. Mukaida, K. Matsushima, G. W. Hunninghake. 1998. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-{kappa}B in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J. Infect. Dis. 177:1275.[Medline]
  67. Law, K., M. Weiden, T. Harkin, K. Tchou-Wong, C. Chi, W. N. Rom. 1996. Increased release of interleukin-1ß, interleukin-6, and tumor necrosis factor-{alpha} by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care 153:799.[Abstract]
  68. Bonizzi, G., J. Piette, M. P. Merville, V. Bours. 1997. Distinct signal transduction pathways mediate nuclear factor-{kappa}B induction by IL-1ß in epithelial and lymphoid cells. J. Immunol. 159:5264.[Abstract]
  69. Devergne, O., A. Marfaing-Koka, T. T. Schall, M. Leger-Ravet, M. Sadick, M. Peuchmaur, M. Crevon, T. Kim, P. Galanaud, D. Emilie. 1994. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J. Exp. Med. 179:1689.[Abstract/Free Full Text]
  70. Donnelly, S. C., R. M. Strieter, S. L. Klunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, C. Haslett. 1993. Interleukin-8 and the development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643.[Medline]



This article has been cited by other articles:


Home page
CVIHome page
P. Mendez-Samperio, E. Miranda, and A. Trejo
Expression and Secretion of Cathelicidin LL-37 in Human Epithelial Cells after Infection by Mycobacterium bovis Bacillus Calmette-Guerin
Clin. Vaccine Immunol., September 1, 2008; 15(9): 1450 - 1455.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Slevogt, L. Maqami, K. Vardarowa, W. Beermann, A. C. Hocke, J. Eitel, B. Schmeck, A. Weimann, B. Opitz, S. Hippenstiel, et al.
Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms
Eur. Respir. J., April 1, 2008; 31(4): 725 - 735.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Rivas-Santiago, R. Hernandez-Pando, C. Carranza, E. Juarez, J. L. Contreras, D. Aguilar-Leon, M. Torres, and E. Sada
Expression of Cathelicidin LL-37 during Mycobacterium tuberculosis Infection in Human Alveolar Macrophages, Monocytes, Neutrophils, and Epithelial Cells
Infect. Immun., March 1, 2008; 76(3): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland
Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages
J. Immunol., March 15, 2007; 178(6): 3767 - 3776.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. E. Harris, J. A. Green, P. T. Elkington, and J. S. Friedland
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion
J. Leukoc. Biol., February 1, 2007; 81(2): 548 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Harris, R. K. Nuttall, P. T. Elkington, J. A. Green, D. E. Horncastle, M. B. Graeber, D. R. Edwards, and J. S. Friedland
Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo
J. Immunol., January 15, 2007; 178(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Lin, H.-W. Cheng, M.-J. Hsu, M.-C. Chen, C.-C. Lin, and B.-C. Chen
c-Src Mediates Thrombin-Induced NF-{kappa}B Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells.
J. Immunol., September 1, 2006; 177(5): 3427 - 3438.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. S. Lopez-Boado, L. M. Cobb, and R. Deora
Bordetella bronchiseptica Flagellin Is a Proinflammatory Determinant for Airway Epithelial Cells
Infect. Immun., November 1, 2005; 73(11): 7525 - 7534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. Debbabi, S. Ghosh, A. B. Kamath, J. Alt, D. E. deMello, S. Dunsmore, and S. M. Behar
Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells
Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L274 - L279.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. I. Wickremasinghe, L. H. Thomas, C. M. O'Kane, J. Uddin, and J. S. Friedland
Transcriptional Mechanisms Regulating Alveolar Epithelial Cell-specific CCL5 Secretion in Pulmonary Tuberculosis
J. Biol. Chem., June 25, 2004; 279(26): 27199 - 27210.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. M. Wright and J. S. Friedland
Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis
J. Leukoc. Biol., June 1, 2004; 75(6): 1086 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. P. Mizgerd, M. M. Lupa, J. Hjoberg, J. C. Vallone, H. B. Warren, J. P. Butler, and E. S. Silverman
Roles for early response cytokines during Escherichia coli pneumonia revealed by mice with combined deficiencies of all signaling receptors for TNF and IL-1
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1302 - L1310.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. M. Price, R. H. Gilman, J. Uddin, S. Recavarren, and J. S. Friedland
Unopposed Matrix Metalloproteinase-9 Expression in Human Tuberculous Granuloma and the Role of TNF-{alpha}-Dependent Monocyte Networks
J. Immunol., November 15, 2003; 171(10): 5579 - 5586.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
P. Mendez-Samperio, H. Ayala, and A. Vazquez
NF-{kappa}B Is Involved in Regulation of CD40 Ligand Expression on Mycobacterium bovis Bacillus Calmette-Guerin-Activated Human T Cells
Clin. Vaccine Immunol., May 1, 2003; 10(3): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Y. Hahn, S. E. Evans, T. J. Kottom, J. E. Standing, R. E. Pagano, and A. H. Limper
Pneumocystis carinii Cell Wall beta -Glucan Induces Release of Macrophage Inflammatory Protein-2 from Alveolar Epithelial Cells via a Lactosylceramide-mediated Mechanism
J. Biol. Chem., January 10, 2003; 278(3): 2043 - 2050.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Hale-Donze, T. Greenwell-Wild, D. Mizel, T. M. Doherty, D. Chatterjee, J. M. Orenstein, and S. M. Wahl
Mycobacterium avium Complex Promotes Recruitment of Monocyte Hosts for HIV-1 and Bacteria
J. Immunol., October 1, 2002; 169(7): 3854 - 3862.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. Di Stefano, G. Caramori, T. Oates, A. Capelli, M. Lusuardi, I. Gnemmi, F. Ioli, K.F. Chung, C.F. Donner, P.J. Barnes, et al.
Increased expression of nuclear factor-{kappa}B in bronchial biopsies from smokers and patients with COPD
Eur. Respir. J., September 1, 2002; 20(3): 556 - 563.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Ameixa and J. S. Friedland
Interleukin-8 Secretion from Mycobacterium tuberculosis-Infected Monocytes Is Regulated by Protein Tyrosine Kinases but Not by ERK1/2 or p38 Mitogen-Activated Protein Kinases
Infect. Immun., August 1, 2002; 70(8): 4743 - 4746.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. Caamano and C. A. Hunter
NF-{kappa}B Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Clin. Microbiol. Rev., July 1, 2002; 15(3): 414 - 429.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer
Innate Immunity to Mycobacterium tuberculosis
Clin. Microbiol. Rev., April 1, 2002; 15(2): 294 - 309.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Yamada, S. Mizuno, M. Reza-Gholizadeh, and I. Sugawara
Relative Importance of NF-kappa B p50 in Mycobacterial Infection
Infect. Immun., November 1, 2001; 69(11): 7100 - 7105.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C.L. Elliott, V.C. Allport, J.A.Z. Loudon, G.D. Wu, and P.R. Bennett
Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells
Mol. Hum. Reprod., August 1, 2001; 7(8): 787 - 790.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
C. Ameixa and J. S. Friedland
Down-Regulation of Interleukin-8 Secretion from Mycobacterium tuberculosis-Infected Monocytes by Interleukin-4 and -10 but Not by Interleukin-13
Infect. Immun., April 1, 2001; 69(4): 2470 - 2476.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. M. Dobos, E. A. Spotts, F. D. Quinn, and C. H. King
Necrosis of Lung Epithelial Cells during Infection with Mycobacterium tuberculosis Is Preceded by Cell Permeation
Infect. Immun., November 1, 2000; 68(11): 6300 - 6310.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. H. Thomas, M. I. Y. Wickremasinghe, M. Sharland, and J. S. Friedland
Synergistic Upregulation of Interleukin-8 Secretion from Pulmonary Epithelial Cells by Direct and Monocyte-Dependent Effects of Respiratory Syncytial Virus Infection
J. Virol., September 15, 2000; 74(18): 8425 - 8433.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wickremasinghe, M. I.
Right arrow Articles by Friedland, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wickremasinghe, M. I.
Right arrow Articles by Friedland, J. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS